ROCKVILLE, Md.--(BUSINESS WIRE)--MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiovascular diagnostic services, today announced that they have achieved a company milestone with 10,000 clinical trial sites spread across five continents currently under management.
